SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

Community sentiment remains heavily divided as TRUMP-linked tokens face intense scrutiny following reports of massive income generation from crypto ventures, leading to widespread investor losses. While some followers continue to promote speculative short-squeeze narratives, critics are aggressively highlighting the token's significant decline and questioning the transparency of these projects.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the community highlights its pivotal role as the foundational operating system for physical AI, robotics, and software-defined vehicles, with significant attention on the upcoming Alloy Kore platform. Investors are actively discussing the stock's long-term potential fueled by widespread industry adoption of QNX and its critical position in high-growth, mission-critical technology sectors.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is seeing increased community engagement fueled by speculation on whale accumulation and potential upcoming network upgrades. Traders are actively debating whether current support levels represent a solid foundation for a bounce or if broader market pressure will continue to weigh on the asset.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Valero Energy is trending as investors monitor a corrective pullback in a bullish structure, with community discussions heavily focused on technical Elliott Wave analysis and potential support levels. Traders are debating whether the current dip presents a strategic entry point before the next anticipated rally, while the broader sector remains in focus amid evolving energy market dynamics.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Market participants are intensely focused on the upcoming Federal Reserve policy decision and conflicting geopolitical headlines from the Middle East, which are driving volatility across major indices. Traders are closely monitoring the divergent performance between defensive value names and tech-heavy AI sectors as the community debates whether the recent price swings represent a broader market correction or a temporary rotation ahead of key corporate earnings.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is trending as investors digest a recent earnings report that featured record ARR growth and improved profitability alongside an 8% workforce reduction. While the stock saw significant downward pressure, the community is actively debating its long-term valuation, potential as an M&A target for tech giants, and its competitive standing within the AI cybersecurity sector.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

Better Home & Finance is trending due to the surprise departure of founder-CEO Vishal Garg and the appointment of interim CEO Daniel Lewis, who is prioritizing cost-cutting to reach profitability. The community is actively debating the company's long-term potential as an AI-driven mortgage infrastructure provider versus its history of volatility, with many traders closely watching the stock for potential short-squeeze activity given the significant short interest and low float.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is generating significant market buzz as investors weigh the company's strong operational output and favorable production cost structure against recent legal and regulatory scrutiny. The community remains deeply divided, with bulls pointing to the company's long-term production growth and strategic expansion phases, while bears remain focused on potential risks from debt obligations and high volatility.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing increased retail interest and active community debate regarding its fair value, with many investors anticipating a potential buyout or major re-rating following its shift toward sustained profitability. While some participants express frustration over persistent price volatility and skepticism toward management, others are monitoring the pediatric rollout of Orladeyo and ongoing institutional accumulation as key catalysts for future growth.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is currently gaining investor attention following positive phase 3 trial results for its COMP360 therapy, fueling strong community sentiment regarding its first-mover advantage and pending FDA regulatory milestones. The community is actively discussing the potential for a strategic partnership or buyout, as the stock remains a focal point for institutional accumulation amid broader sector momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CorMedix is seeing active investor focus as the company balances strong institutional backing with uncertainty surrounding the transition away from TDAPA reimbursement. Community sentiment remains split between optimism for DefenCath's potential as a standard of care and frustration over management communication, clinical trial updates, and the impact of the recent commercial leadership changes.

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates

Syndax (SNDX) delivered earnings and revenue surprises of -22.22% and -11.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates

Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of -10.96% and -36.76%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue?

Exelixis (EXEL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CRMD's Growth Story Expands Beyond DefenCath Into New Trends

CorMedix broadens beyond DefenCath with Melinta assets, Rezzayo potential and cost synergies as reimbursement changes test long-term earnings durability.

Is CRMD Stock a Buy Now After Strong Growth and New Risks?

CorMedix posted surging DefenCath-led revenue and stronger profitability, but reimbursement changes and execution risks could shape the stock's next phase.

CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path

CorMedix is shifting from a single-product launch story as DefenCath drives revenue and Rezzayo adds long-term potential despite reimbursement headwinds.

CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised

CorMedix beats Q1 estimates as DefenCath demand surges and raises 2026 guidance on stronger execution and growing profitability.

CorMedix (CRMD) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

CRMD Stock Soared 18% Today – Here’s What Fueled CorMedix’s Triple-Digit Q1 Revenue Surge

Equity

CorMedix reported strong Q1 results, with revenue coming at $127.4 million, far exceeding Wall Street’s guidance of around $105 million, according to Fiscal.ai data.

CorMedix (CRMD) Q1 Earnings and Revenues Beat Estimates

CorMedix (CRMD) delivered earnings and revenue surprises of +24.64% and +16.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

$CRMD Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.48 up 50.00% YoY
• Reported revenue of $127.43M up 226.05% YoY
• CorMedix increased its full-year 2026 net revenue guidance to a range of $325M to $345M and adjusted EBITDA guidance to a range of $115M to $135M.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$7.44
Prev Close	$7.51
Open	$7.58
Dividend Yield	0.00%
50-Day Moving Average	$8.21
Beta	0.98
Avg. Volume	940,739.12
PE Ratio	3.54

52-Week High	$14.96
52-Week Low	$6.13
Market Capitalization	$583.68M
EPS (Annual)	$2.03
Price to Book	1.33
Revenue Per Employee	$1.63M

Feed

News

Sentiment

Earnings

Fundamentals

Info